Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era

References

• Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma. Lancet. 2009;374(9686 ):324–339. doi:10.1016/S0140-6736(09)60221-X19541364
   PubMed Web of Science ®Google Scholar
• Romano A, Laura Parrinello N, Cerchione C, et al. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents. Blood Cancer J. 2017;7(12 ):649. doi:10.1038/s41408-017-0019-629242558
   PubMedGoogle Scholar
• Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111(6 ):2962–2972. doi:10.1182/blood-2007-10-07802218332230
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1 ):5–29. doi:10.3322/caac.2125425559415
   PubMed Web of Science ®Google Scholar
• Benboubker L, Dimopoulos MA, Dispenzieri A, et al. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. New Engl J Med. 2014;371(10 ):906–917. doi:10.1056/NEJMoa140255125184863
   PubMed Web of Science ®Google Scholar
• Gay F, Oliva S, Petrucci MT, et al. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial. Lancet Oncol. 2015;16(16 ):1617–1629. doi:10.1016/S1470-2045(15)00389-726596670
   PubMed Web of Science ®Google Scholar
• Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015;33(26 ):2863. doi:10.1200/JCO.2015.61.226726240224
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5 ):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917 ):860–867. doi:10.1038/nature0132212490959
   PubMed Web of Science ®Google Scholar
• Mantovani A. Cancer – inflammation by remote control. Nature. 2005;435(7043 ):752–753. doi:10.1038/435752a15944689
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6 ):883–899. doi:10.1016/j.cell.2010.01.02520303878
   PubMed Web of Science ®Google Scholar
• Fu Y, Mao YZ, Chen SQ, Yang AK, Zhang Q, Gao J-X. A novel inflammation- and nutrition-based prognostic system for patients with laryngeal squamous cell carcinoma: combination of Red Blood Cell Distribution Width and Body Mass Index (COR-BMI). PLoS One. 2016;11(9 ):e0163282. doi:10.1371/journal.pone.016328227658208
   PubMed Web of Science ®Google Scholar
• Wang Y, He SS, Cai XY, et al. The Novel Prognostic Score Combining Red Blood Cell Distribution Width and Body Mass Index (COR-BMI) has prognostic impact for survival outcomes in nasopharyngeal carcinoma. J Cancer. 2018;9(13 ):2295–2301. doi:10.7150/jca.2483830026824
   PubMed Web of Science ®Google Scholar
• Cho Y, Kim JW, Yoon HI, Lee CG, Keum KC, Lee IJ. The prognostic significance of neutrophil-to-lymphocyte ratio in head and neck cancer patients treated with radiotherapy. J Clin Med. 2018;7(12 ):512. doi:10.3390/jcm7120512
   PubMed Web of Science ®Google Scholar
• Chen Q, Yang LX, Li XD, et al. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumor Biol. 2015;36(7 ):5283–5289. doi:10.1007/s13277-015-3188-6
   PubMedGoogle Scholar
• Shimada H, Oohira G, Okazumi S, et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surgeons. 2004;198(5 ):737–741. doi:10.1016/j.jamcollsurg.2004.01.022
   PubMed Web of Science ®Google Scholar
• Aoe K, Hiraki A, Ueoka H, et al. Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration. 2004;71(2 ):170–173. doi:10.1159/00007667915031573
   PubMed Web of Science ®Google Scholar
• Sun C, Ye J-N, Wang H, Zhu J-W, Zhou X, Li J-Y. [Prognostic value of red blood cell distribution width in senile patients with non-trans planted multiple myeloma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27(1 ):115–122. doi:10.7534/j.issn.1009-2137.2019.01.01930738457
   PubMedGoogle Scholar
• Kelkitli E, Atay H, Cilingir F, et al. Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio. Ann Hematol. 2014;93(5 ):841–846. doi:10.1007/s00277-013-1978-824337486
   PubMed Web of Science ®Google Scholar
• Kim DS, Yu ES, Kang KW, et al. Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma. Korean J Intern Med. 2017;32(4 ):711–721. doi:10.3904/kjim.2016.05427809455
   PubMed Web of Science ®Google Scholar
• Zhou D, Xu PP, Peng MX, et al. Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma. Clin Chim Acta. 2018;481:34–41. doi:10.1016/j.cca.2018.02.00929452082
   PubMed Web of Science ®Google Scholar
• Lee SM, Russell A, Hellawell G. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma. Korean J Urol. 2015;56(11 ):749–755. doi:10.4111/kju.2015.56.11.74926568792
   PubMedGoogle Scholar
• Jia W, Wu J, Jia H, et al. The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-to-monocyte ratio for predicting the long-term survival of triple-negative breast cancer patients. PLoS One. 2015;10(11 ):e0143061. doi:10.1371/journal.pone.014306126580962
   PubMed Web of Science ®Google Scholar
• Roxburgh CSD, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1 ):149–163. doi:10.2217/fon.09.13620021215
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255 ):539–545. doi:10.1016/S0140-6736(00)04046-011229684
   PubMed Web of Science ®Google Scholar
• Thompson WG, Meola T, Lipkin M Jr, Freedman ML. Red cell distribution width, mean corpuscular volume, and transferrin saturation in the diagnosis of iron deficiency. Arch Intern Med. 1988;148(10 ):2128–2130.3178371
   PubMedGoogle Scholar
• Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4 ):628–632.19391664
   PubMed Web of Science ®Google Scholar
• Warwick R, Mediratta N, Shackcloth M, Shaw M, McShane J, Poullis M. Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(1 ):108–113. doi:10.1093/ejcts/ezt27523711463
   PubMed Web of Science ®Google Scholar
• Albayrak S, Zengin K, Tanik S, Bakirtas H, Imamoglu A, Gurdal M. Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev. 2014;15(18 ):7781–7784. doi:10.7314/apjcp.2014.15.18.778125292063
   PubMedGoogle Scholar
• Arbel Y, Weitzman D, Raz R, et al. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost. 2014;111(2 ):300–307. doi:10.1160/TH13-07-056724173039
   PubMed Web of Science ®Google Scholar
• Solak Y, Yilmaz MI, Saglam M, et al. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease. Am J Med Sci. 2014;347(2 ):118–124. doi:10.1097/MAJ.0b013e3182996a9623928544
   PubMed Web of Science ®Google Scholar
• Balta S, Aydogan M, Demirkol S, Cakar M, Akgul EO, Sarlak H. Red cell distribution width: a novel and simple predictor of mortality in chronic obstructive pulmonary disease. Copd. 2014;11(4 ):475–476. doi:10.3109/15412555.2013.81344924568244
   PubMedGoogle Scholar
• Podhorecka M, Halicka D, Szymczyk A, et al. Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia. Oncotarget. 2016;7(22 ):32846–32853. doi:10.1038/nature0132227147570
   PubMedGoogle Scholar
• Lee H, Kong SY, Sohn JY, et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Biomed Res Int. 2014;2014:145619.24963470
   PubMed Web of Science ®Google Scholar
• Jilma B, Blann A, Pernerstorfer T, et al. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med. 1999;159(3 ):857–863. doi:10.1164/ajrccm.159.3.980508710051263
   PubMed Web of Science ®Google Scholar
• Dionigi R, Dominioni L, Benevento A, et al. Effects of surgical trauma of laparoscopic vs. open cholecystectomy. Hepatogastroenterology. 1994;41(5 ):471–476.7851857
   PubMedGoogle Scholar
• O’Mahony JB, Palder SB, Wood JJ, et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma. 1984;24(10 ):869–875. doi:10.1097/00005373-198410000-000016238173
   PubMedGoogle Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts – rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1 ):5–14.11723675
   PubMedGoogle Scholar
• Carreau NA, Diefenbach CS. Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist. Ther Adv Hematol. 2019;10:2040620719846451. doi:10.1177/204062071984645131105921
   PubMed Web of Science ®Google Scholar
• Souto JC, Vila L, Bru A. Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors. Med Res Rev. 2011;31(3 ):311–363. doi:10.1002/med.2018519967776
   PubMed Web of Science ®Google Scholar
• Piccard H, Muschel RJ, Opdenakker G. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol. 2012;82(3 ):296–309. doi:10.1016/j.critrevonc.2011.06.00421798756
   PubMed Web of Science ®Google Scholar
• Talmadge JE, Donkor M, Scholar E. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev. 2007;26(3–4 ):373–400. doi:10.1007/s10555-007-9072-017717638
   PubMed Web of Science ®Google Scholar
• Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, Kusunoki M. Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg. 2010;34(2 ):285–290. doi:10.1007/s00268-009-0302-119997918
   PubMed Web of Science ®Google Scholar
• Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3 ):181–184. doi:10.1002/jso.2032916118772
   PubMed Web of Science ®Google Scholar
• Halazun KJ, Hardy MA, Rana AA, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250(1 ):141–151. doi:10.1097/SLA.0b013e3181a77e5919561458
   PubMed Web of Science ®Google Scholar
• Porrata LF, Ristow K, Habermann T, Inwards DJ, Micallef IN, Markovic SN. Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio. Am J Hematol. 2010;85(11 ):896–899. doi:10.1002/ajh.2184920842639
   PubMed Web of Science ®Google Scholar
• Jain S, Harris J, Ware J. Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol. 2010;30(12 ):2362–2367. doi:10.1161/ATVBAHA.110.20751421071699
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59(6 ):1295–1300.10096562
   PubMed Web of Science ®Google Scholar
• Monreal M, Fernandez-Llamazares J, Pinol M, et al. Platelet count and survival in patients with colorectal cancer – a preliminary study. Thromb Haemost. 1998;79(5 ):916–918.9609220
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Bucana CD, Akagi Y, et al. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res. 1998;4(2 ):429–434.9516932
   PubMed Web of Science ®Google Scholar
• Yu D, Liu B, Zhang L, Du K. Platelet count predicts prognosis in operable non-small cell lung cancer. Exp Ther Med. 2013;5(5 ):1351–1354. doi:10.3892/etm.2013.100323737877
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim K, Kim BS, et al. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry. Acta Haematol. 2009;122(4 ):200–210. doi:10.1159/00025302719887776
   PubMed Web of Science ®Google Scholar
• Fritz E, Ludwig H, Scheithauer W, Sinzinger H. Shortened platelet half-life in multiple myeloma. Blood. 1986;68(2 ):514–520.3730614
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kawakamil M, Hara Y, et al. Combined evaluation of the glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer. Hepato-Gastroenterology. 2014;61(133 ):1359–1362.25436311
   PubMedGoogle Scholar
• Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158. doi:10.1186/1471-2407-13-15823530866
   PubMed Web of Science ®Google Scholar
• Lee AH, Gillett CE, Ryder K, Fentiman IS, Miles DW, Millis RR. Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology. 2006;48(6 ):692–701. doi:10.1111/j.1365-2559.2006.02410.x16681685
   PubMed Web of Science ®Google Scholar
• Klintrup K, Makinen JM, Kauppila S, et al. Inflammation and prognosis in colorectal cancer. Eur J Cancer. 2005;41(17 ):2645–2654. doi:10.1016/j.ejca.2005.07.01716239109
   PubMed Web of Science ®Google Scholar